FBLG – fibrobiologics, inc. (US:NASDAQ)
Stock Stats
News
FibroBiologics to Present at the BIO Investment & Growth Summit
FibroBiologics (FBLG) had its "buy" rating reaffirmed by HC Wainwright.
FibroBiologics (FBLG) had its price target lowered by D. Boral Capital from $15.00 to $7.00. They now have a "buy" rating on the stock.
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
FibroBiologics Granted Extension by Nasdaq to Regain Compliance
Form 10-K FibroBiologics, Inc. For: Dec 31
Form 8-K FibroBiologics, Inc. For: Feb 20
Form 8-K FibroBiologics, Inc. For: Feb 03
Form 8-K FibroBiologics, Inc. For: Dec 30
Form EFFECT FibroBiologics, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.